Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2009
09/03/2009US20090222951 Biosynthesis of polyunsaturated fatty acids (PUFAs); use of transgenic organism modified with polypeptides having Delta-5 elongase or Delta 6-desaturase activity; production of unsaturated omega-3 fatty acids and triglycerides with an increased content of unsaturated fatty acids
09/03/2009US20090222950 Soybean Cultivar S070157
09/03/2009US20090222949 Constructs and Methods for Generating Plants Exhibiting Altered Plasmodesmatal Conductance
09/03/2009US20090222948 Method for modifying plant morphology, biochemistry and physiology
09/03/2009US20090222946 An O-methyltransferase and its use in producing xanthohumol by methylating desmethylxanthohumol
09/03/2009US20090222945 Brittle stalk 2 polynucleotides, polypeptides, and uses thereof
09/03/2009US20090222944 Use Of Stomatin (STM1) Polynucleotides For Achieving A Pathogen Resistance In Plants
09/03/2009US20090222942 Generation of plants with improved pathogen resistance
09/03/2009US20090222941 Marker for Selecting an Aphanomyces Cochlioides-Resistant Variety and Selection Method Therefor
09/03/2009US20090222937 Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof
09/03/2009US20090222936 Recombinant Expression of Multiprotein Complexes Using Polygenes
09/03/2009US20090222935 Transgenic animals and uses thereof
09/03/2009US20090222932 Alzheimer's disease animal model, method for obtaining same and uses thereof
09/03/2009US20090222931 Novel identified oncogene with kinase-domain (nok)
09/03/2009US20090221808 Process for the Preparation of Nucleic Acid Duplexes
09/03/2009US20090221807 2' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid
09/03/2009US20090221802 heterodimeric receptor complex comprising a receptor polypeptide and a interleukin-2 gamma receptor polypeptide, used for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; antibodies; immunology
09/03/2009US20090221799 Novel Fluorescent and Colored Proteins, and Polynucleotides That Encode These Proteins
09/03/2009US20090221794 Human Protooncogene and Protein Encoded By Same
09/03/2009US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products
09/03/2009US20090221685 Oligomeric compounds and compositions for the use in modulation of micrornas
09/03/2009US20090221684 Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof
09/03/2009US20090221681 Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
09/03/2009US20090221680 Aptamers that bind thrombin with high affinity
09/03/2009US20090221678 target heat shock protein (hsp) 27 in vivo; antisense oligonucleotide or RNAi nucleotide inhibitor with sequence specificity for hsp27 mRNA; injectable dosage unit form
09/03/2009US20090221677 Methods for Reducing Body Fat and Increasing Lean Body Mass by Reducing Stearoyl-COA Desaturase 1 Activity
09/03/2009US20090221674 Compositions and methods for therapy and diagnosis of cancer
09/03/2009US20090221670 Method for diagnosis and treatment of a mental disease
09/03/2009US20090221520 Polyene Antibiotics, Compositions Containing Said Antibiotics, Method and Micro-Organisms Used to Obtain Same and Applications Thereof
09/03/2009US20090221509 Tumour-associated peptides binding to MHC-molecules
09/03/2009US20090221501 toxin complex (TC) proteins, obtained from Xenorhabdus, Photorhabdus, and Paenibacillus; toxicity of an insectidal protein is enhanced by a potentiator protein of a different organism; reduces the number of genes (and transformation events) needed to be coexpressed by transgenic plants for insect control
09/03/2009US20090221499 Production in E. coli of a lipidated fusion protein containing a lipidating sequence derived from Ag473 and a target polypeptide; for use in induction of immune responses
09/03/2009US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals
09/03/2009US20090221483 Antimicrobial Cathelicidin Peptides
09/03/2009US20090221482 Tissue protective peptides and uses thereof
09/03/2009US20090221476 Peptide Capable of Altering Tubulin Polymerization and use Thereof for Inhibiting Cell Proliferation
09/03/2009US20090221474 Histone deacetylases, and uses related thereto
09/03/2009US20090221445 Cancer Diagnostic Panel
09/03/2009US20090221442 Substrates and screening methods for transport proteins
09/03/2009US20090221440 Methods and compositions related to identifying protein-protein interactions
09/03/2009US20090221436 Process for determining target function and identifying drug leads
09/03/2009US20090221078 Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate
09/03/2009US20090221077 Process for producing cytotoxic lymphocytes
09/03/2009US20090221065 Composition for suppressing the expression of fucosyltransferase
09/03/2009US20090221051 Xylanases, nucleic acids encoding them and methods for making and using them
09/03/2009US20090221049 Thermophilic Organisms For Conversion Of Lignocellulosic Biomass To Ethanol
09/03/2009US20090221043 Mutant of the prob gene from coryneform bacteria
09/03/2009US20090221040 immunizing an animal with a mixture of different histidine fusion polypeptides and obtaining polyclonal antibodies directed against the histidine portion of the fusion polypeptides from the serum of the animal; rapid
09/03/2009US20090221039 Fusion proteins between plant cell-wall degrading enzymes and a swollenin, and their uses
09/03/2009US20090221038 Twin-Arginine Translocation (TAT) Streptomyces Signal Sequences
09/03/2009US20090221036 Recombinant anti-cd4 antibodies for human therapy
09/03/2009US20090221035 Systems and methods for protein production
09/03/2009US20090221034 Lipolytic Enzyme Variant With Improved Stability And Polynucleotides Encoding Same
09/03/2009US20090221033 Polypeptides Having Lipase Activity And Polynucleotides Encoding Same
09/03/2009US20090221032 Entropic bristle domain sequences and their use in recombinant protein production
09/03/2009US20090221031 Novel group of esterases for the production of fine and speciality chemicals
09/03/2009US20090221029 Pfu replication accessory factors and methods of use
09/03/2009US20090221027 Use of a bacillus meti gene to improve methionine production in microorganisms
09/03/2009US20090221016 Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof
09/03/2009US20090221007 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen
09/03/2009US20090221006 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen
09/03/2009US20090220999 Antibodies immunoreactive with mutant 5-enolpyruvlshikimate-3-phosphate synthase
09/03/2009US20090220978 Methods for detection and quantification of analytes in complex mixtures
09/03/2009US20090220977 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
09/03/2009US20090220962 Nucleotide sequences coding cyanopeptide metabolites for potential use as angiotensin converting enzyme inhibitors and in treatment of aterial stenosis and high blood pressure
09/03/2009US20090220950 Simultaneous quantification of nucleic acids in diseased cells
09/03/2009US20090220943 Hcv genotyping and phenotyping
09/03/2009US20090220673 Soybean Cultivar 7043182
09/03/2009US20090220672 Soybean Cultivar 306924721
09/03/2009US20090220671 Soybean Cultivar 7614385
09/03/2009US20090220670 Promoter-based silencing
09/03/2009US20090220589 Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
09/03/2009US20090220584 Amphoteric Liposome Formulation
09/03/2009US20090220582 Method of cancer treatment using sirna silencing
09/03/2009US20090220549 Reagents for recombinogenic engineering and use thereof
09/03/2009US20090220543 Expression of Proteins in Plants
09/03/2009US20090220540 Helicobacter System and Uses Thereof
09/03/2009US20090220539 Recombinant Mononegaviral Virus Vectors
09/03/2009US20090220538 vaccine for staphylococcal infections
09/03/2009US20090220537 Vaccine delivery system
09/03/2009US20090220534 Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopes
09/03/2009US20090220532 Agents and methods based on the use of the eda domian of fibronectin
09/03/2009US20090220527 Affinity optimized epha2 agonistic antibodies and methods of use thereof
09/03/2009US20090220521 Anti MIF Antibodies
09/03/2009US20090220517 Method for producing epitomers and their uses on carrier microorganisms
09/03/2009US20090220514 ADAM10 and its Uses Related to Infection
09/03/2009US20090220513 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
09/03/2009US20090220512 Genes and polypeptides relating to prostate cancers
09/03/2009US20090220511 human polypeptides named IFN (interferon)- lambda 1, IFN- lambda 2 and IFN- lambda 3 and IFN- lambda R1; antiviral agents
09/03/2009US20090220510 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer
09/03/2009US20090220504 Combinatorial therapy
09/03/2009US20090220503 Method for treating cancers with increased ras signaling
09/03/2009US20090220502 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
09/03/2009US20090220498 Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma
09/03/2009US20090220495 Cancer Related Genes (PRLR)
09/03/2009US20090220494 Antibodies produced in a transgenic avian
09/03/2009US20090220491 Binding agents which inhibit myostatin
09/03/2009US20090220486 Antibodies and uses thereof
09/03/2009US20090220485 Method for isolation of soluble polypeptides
09/03/2009US20090220484 Rage/Diaphanous Interaction and Related Compositions and Methods